Axplora Invests €50M in GLP-1 Manufacturing Expansion at Mourenx, France

Axplora, GLP-1, manufacturing expansion, Mourenx, France, CDMO, API production, chromatography, diabetes, obesity, biologic therapies

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)